Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 36.30% vs 15.91% in Sep 2025
Consolidate Net Profit
YoY Growth in quarter ended Sep 2026 is 81.46% vs 20.40% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is 78.43% vs 31.94% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is 57.90% vs 28.81% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025
Compare Quarterly Results Of Alembic Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 21.11% vs 16.35% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 36.30% vs 15.91% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is 93.66% vs -14.62% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 81.46% vs 20.40% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 69.73% vs 45.60% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 78.43% vs 31.94% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 38.57% vs 22.38% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 57.90% vs 28.81% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025